Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Sakinc, Türkan ^a,b   Baars, Barbara ^b   Wüppenhorst, Nicole ^a   Kist, Manfred ^a   Huebner, Johannes ^a   Opferkuch, Wolfgang ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

23S rRNA; Helicobacter pylori; Synergistic effect

Indexed keywords

HELICOBACTER PYLORI;

AMOXICILLIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; CLARITHROMYCIN; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 23S;

EID: 84867894482     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-603     Document Type: Article

References (11)

1. Ecology of Helicobacter pylori in the human stomach. Blaser MJ, J Clin Investig 1997 100 759 762 10.1172/JCI119588 9259572
2. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. De Francesco V, Zullo A, Lerardi E, et al. J Antimicrob Chemother 2010 65 327 332 10.1093/jac/dkp445 20008044
3. Prevalencia de la Resistencia a metronidazol, claritromicina y tetraciclina en Helicobacter pylori: studio de base hospitalaria. Vallejos C, Garrido L, Caceres D, et al. Rev Med Chile 2007 135 287 293 17505573
4. Cloning and sequence analysis of the two copies of 23S rRNA genes from Helicobacter pylori and association of clarithromycin resistance with 23 rRNA mutations. Taylor DE, Ge Z, Purych D, Antimicrob Agents Chemother 1997 41 2621 2628 9420030
5. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Ge W, Taylor DE, Antimicrob Agents Chemother 1998 42 1952 1958 9687389
6. b. Wurzer HL, Rodrigo D, Stamler D, et al. Pharmacol Ther 1998 11 943 952
7. Die In-vitro-Wirksamkeit von Antibiotika-Kombinationen auf Helicobacter pylori. Baars B, Sakinc T, Opferkuch W, Chemotherapie Journal 2008 17 100 106
8. Antimicrobial combinations. Eliopoulos GM, Moellering RC, Antibiotics in laboratory medicine Baltimore Md: The Williams& Williams Co, Lorian V, 4 1996 330 396
9. Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism. Agudo S, Pérez-Pérez G, Alarcón T, et al. Rev Esp Quimioter 2011 24 32 36 21412667
10. Novel mutation in 23S rRNA that confers low-lewel resistance to clarithromycin in Helicobacter pylori. Rimbara E, Noguchi N, Sasatsu M, Antimicrob Agents Chemother 2008 52 3465 3466 10.1128/AAC.00445-08 18606842
11. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. Hirata K, Suzuki H, Nishizawa T, et al. J Gastroenterol Hepatol 2010 1 75 79